News

Strides Pharma Science Limited submitted a certificate to the National Stock Exchange of India Limited and BSE Limited on October 7, 2026, in compliance with regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, detailing securities dematerialized and rematerialized for the quarter ended September 30, 2026, with KFin Technologies Limited acting as the Registrar and Share Transfer Agent.

Strides Pharma Science Limited informed the BSE Limited and National Stock Exchange of India Limited that the trading window for dealing in shares of the company will be closed from October 1, 2026, until 48 hours after the declaration of financial results for the quarter ended September 30, 2026.

Net profit of Strides Pharma Science rose 57.52% to Rs 156.91 crore in the quarter ended June 2026 as against Rs 99.61 crore during the previous quarter ended June 2025. Sales rose 13.01% to Rs 1265.41 crore in the quarter ended June 2026 as against Rs 1119.74 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales1265.411119.74 13 OPM %18.0619.48 - PBDT192.82179.30 8 PBT136.42130.41 5 NP156.9199.61 58 Powered by Capital Market - Live News

Strides Pharma Science will hold a meeting of the Board of Directors of the Company on 31 July 2026.

Strides Pharma Science announced that the 35th Annual General Meeting(AGM) of the company will be held on 14 August 2026.